Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Choi Youn Woong
{{company.company_channel.channel_name}}
Media Room
Latest
Photos
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Follow :
X
Company Profile
Media Room
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.title}}
loading
The End
Network Errors Please Retry
{{selectname}}
{{showName}}
{{selectall}}
{{option}}
DX&VX Selected for Korea's First ARPA-H Project in 2024, Focusing on Room Temperature and Extra-Long-Term Vaccine Storage Technology
2024-11-01 21:00
World-Renowned Scientist Wah Chiu, Stanford University Professor and Honorary Advisor to Pohang City, visited Korea at the invitation of the Coree Group
2024-08-26 21:00
DX&VX is on Track and Accelerating the Development of Oral Obesity Treatment
2024-07-18 21:00
Inaugural 'Korea Medical Innovation Research Forum' regular seminar, a success
2024-04-19 21:00
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS]
2024-01-03 22:00
Dx&Vx co-develops a bio-healthcare big data platform with LG CNS
2023-12-20 22:00
DxVx, plans to make a license-in agreement of OVM-200 and conduct clinical trials in Asia
2023-11-24 22:00
DxVx, won the governmental project to develop diagnostic sensor kit for adult diseases
2023-06-09 21:00
Avixgen accelerates the progress on new drug pipeline development
2023-05-24 21:00
DxVx appoints Yong Gu Lee as new CEO and Kevin Kwon as the new president
2023-05-16 21:00
DxVx Co., Ltd.'s affiliated company, Oxford Vacmedix (OVM) successfully completed Phase 1a in clinical trial of novel cancer vaccine OVM-200
2023-03-30 17:39
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx
2022-10-13 21:00
1